questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Thiénopyridines
Thiénopyridines : Questions médicales fréquentes
Diagnostic
5
Thrombose
Échographie
Angiographie
D-dimère
Coagulation sanguine
Tests de laboratoire
Embolie
Douleur thoracique
Essoufflement
Thiénopyridines
Fonction plaquettaire
Événements thromboemboliques
Réaction indésirable
Saignement
Ecchymose
Symptômes
5
Effets secondaires
Saignement
Troubles gastro-intestinaux
Hémorragie
Saignement de nez
Selles noires
Allergie
Éruption cutanée
Démangeaison
Thrombocytopénie
Ecchymose
Fatigue
Réaction cutanée
Rougeur
Démangeaison
Prévention
5
Prévention
Événements thromboemboliques
Mode de vie sain
Diététique
Vitamine K
Alcool
Risque de saignement
Activités à risque
Consultation médicale
Examens réguliers
Tests sanguins
Fonction hépatique
Éducation des patients
Effets secondaires
Adhésion au traitement
Traitements
5
Thiénopyridines
Agrégation plaquettaire
Antithrombotiques
Clopidogrel
Prasugrel
Ticagrelor
Infarctus
AVC
Procédures coronariennes
Surveillance
Fonction plaquettaire
Saignement
Interactions médicamenteuses
AINS
Anticoagulants
Complications
5
Complications
Hémorragie
Thrombocytopénie
Hémorragie
Arrêt du médicament
Consultation médicale
Thrombose
Interruption de traitement
Suivi médical
Prévention
Surveillance
Éducation des patients
Réaction allergique
Difficultés respiratoires
Éruption cutanée
Facteurs de risque
5
Facteurs de risque
Obésité
Tabagisme
Âge
Risque thrombotique
Circulation sanguine
Hérédité
Thrombose
Antécédents familiaux
Mode de vie
Sédentarité
Alimentation
Médicaments
Anticoagulants
AINS
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thiénopyridines : Questions médicales les plus fréquentes",
"headline": "Thiénopyridines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thiénopyridines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-27",
"dateModified": "2026-02-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thiénopyridines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérobicycliques",
"url": "https://questionsmedicales.fr/mesh/D006574",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérobicycliques",
"code": {
"@type": "MedicalCode",
"code": "D006574",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ticlopidine",
"alternateName": "Ticlopidine",
"url": "https://questionsmedicales.fr/mesh/D013988",
"about": {
"@type": "MedicalCondition",
"name": "Ticlopidine",
"code": {
"@type": "MedicalCode",
"code": "D013988",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.928.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Clopidogrel",
"alternateName": "Clopidogrel",
"url": "https://questionsmedicales.fr/mesh/D000077144",
"about": {
"@type": "MedicalCondition",
"name": "Clopidogrel",
"code": {
"@type": "MedicalCode",
"code": "D000077144",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.928.500.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Thiénopyridines",
"alternateName": "Thienopyridines",
"code": {
"@type": "MedicalCode",
"code": "D058924",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yongqiang Liu",
"url": "https://questionsmedicales.fr/author/Yongqiang%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Jiangsu Vcare PharmaTech Co., Ltd., 15 Wanshou Road, Nanjing 211800, China."
}
},
{
"@type": "Person",
"name": "Xiaojuan Lai",
"url": "https://questionsmedicales.fr/author/Xiaojuan%20Lai",
"affiliation": {
"@type": "Organization",
"name": "Jiangsu Vcare PharmaTech Co., Ltd., 15 Wanshou Road, Nanjing 211800, China."
}
},
{
"@type": "Person",
"name": "Yanchun Gong",
"url": "https://questionsmedicales.fr/author/Yanchun%20Gong",
"affiliation": {
"@type": "Organization",
"name": "Jiangsu Vcare PharmaTech Co., Ltd., 15 Wanshou Road, Nanjing 211800, China."
}
},
{
"@type": "Person",
"name": "Xuefang Liu",
"url": "https://questionsmedicales.fr/author/Xuefang%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Jiangsu Vcare PharmaTech Co., Ltd., 15 Wanshou Road, Nanjing 211800, China."
}
},
{
"@type": "Person",
"name": "Yongguo Li",
"url": "https://questionsmedicales.fr/author/Yongguo%20Li",
"affiliation": {
"@type": "Organization",
"name": "Hua Medicine (Shanghai) Ltd., 275 Ai Di Sheng Road, Shanghai 201203, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Comparing Allergist and Cardiologist Considerations for the Optimal Management of Thienopyridines Hypersensitivity.",
"datePublished": "2019-00-00",
"url": "https://questionsmedicales.fr/article/30215337",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2174/1871530318666180914121758"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cold Snare Polypectomy in Patients Taking Dual Antiplatelet Therapy: A Randomized Trial of Discontinuation of Thienopyridines.",
"datePublished": "2019-10-00",
"url": "https://questionsmedicales.fr/article/31599746",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14309/ctg.0000000000000091"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial.",
"datePublished": "2019-06-01",
"url": "https://questionsmedicales.fr/article/31017637",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamacardio.2019.1049"
}
},
{
"@type": "ScholarlyArticle",
"name": "In-flow photooxygenation of aminothienopyridinones generates iminopyridinedione PTP4A3 phosphatase inhibitors.",
"datePublished": "2019-02-27",
"url": "https://questionsmedicales.fr/article/30746541",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/c9ob00025a"
}
},
{
"@type": "ScholarlyArticle",
"name": "Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report.",
"datePublished": "2020-00-00",
"url": "https://questionsmedicales.fr/article/31113348",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2174/1871523018666190522105055"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Thiénopyridines",
"item": "https://questionsmedicales.fr/mesh/D058924"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thiénopyridines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thiénopyridines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thiénopyridines",
"description": "Comment diagnostiquer une thrombose ?\nQuels tests pour évaluer le risque thrombotique ?\nQuels symptômes indiquent une embolie ?\nComment évaluer l'efficacité des thiénopyridines ?\nQuels signes cliniques d'une réaction indésirable ?",
"url": "https://questionsmedicales.fr/mesh/D058924#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thiénopyridines",
"description": "Quels sont les effets secondaires des thiénopyridines ?\nComment reconnaître une hémorragie liée aux thiénopyridines ?\nQuels symptômes d'allergie aux thiénopyridines ?\nQuels signes d'une thrombocytopénie ?\nComment identifier une réaction cutanée ?",
"url": "https://questionsmedicales.fr/mesh/D058924#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thiénopyridines",
"description": "Comment prévenir les événements thromboemboliques ?\nQuels conseils diététiques pour les patients sous thiénopyridines ?\nComment gérer le risque de saignement ?\nQuels examens réguliers pour les patients sous thiénopyridines ?\nComment éduquer les patients sur les thiénopyridines ?",
"url": "https://questionsmedicales.fr/mesh/D058924#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thiénopyridines",
"description": "Comment les thiénopyridines agissent-elles ?\nQuelles sont les principales thiénopyridines ?\nQuand prescrire des thiénopyridines ?\nComment surveiller le traitement par thiénopyridines ?\nQuels médicaments interagissent avec les thiénopyridines ?",
"url": "https://questionsmedicales.fr/mesh/D058924#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thiénopyridines",
"description": "Quelles sont les complications possibles des thiénopyridines ?\nComment gérer une hémorragie due aux thiénopyridines ?\nQuels risques de thrombose sous thiénopyridines ?\nComment prévenir les complications liées aux thiénopyridines ?\nQuels signes d'une réaction allergique grave ?",
"url": "https://questionsmedicales.fr/mesh/D058924#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thiénopyridines",
"description": "Quels facteurs augmentent le risque de thrombose ?\nComment l'âge influence-t-il le risque thrombotique ?\nQuel rôle joue l'hérédité dans la thrombose ?\nComment le mode de vie affecte-t-il le risque thrombotique ?\nQuels médicaments augmentent le risque de saignement ?",
"url": "https://questionsmedicales.fr/mesh/D058924#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une thrombose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic de thrombose se fait par échographie, angiographie ou tests sanguins."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer le risque thrombotique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le dosage de la D-dimère et des tests de coagulation sanguine."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une embolie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur thoracique, essoufflement et toux avec sang."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des thiénopyridines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des tests de fonction plaquettaire et des événements thromboemboliques."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques d'une réaction indésirable ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des saignements inhabituels, des ecchymoses et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des thiénopyridines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des saignements, des maux de tête et des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hémorragie liée aux thiénopyridines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des saignements de nez, des gencives et des selles noires."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'allergie aux thiénopyridines ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent éruptions cutanées, démangeaisons et gonflement du visage."
}
},
{
"@type": "Question",
"name": "Quels signes d'une thrombocytopénie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des ecchymoses faciles, des saignements prolongés et fatigue."
}
},
{
"@type": "Question",
"name": "Comment identifier une réaction cutanée ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une réaction cutanée se manifeste par des rougeurs, des démangeaisons ou des cloques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les événements thromboemboliques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'utilisation de thiénopyridines, un mode de vie sain et l'exercice."
}
},
{
"@type": "Question",
"name": "Quels conseils diététiques pour les patients sous thiénopyridines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les aliments riches en vitamine K et limitez l'alcool pour réduire les risques."
}
},
{
"@type": "Question",
"name": "Comment gérer le risque de saignement ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les activités à risque, surveillez les signes de saignement et consultez un médecin."
}
},
{
"@type": "Question",
"name": "Quels examens réguliers pour les patients sous thiénopyridines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers incluent des tests sanguins et des évaluations de la fonction hépatique."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les thiénopyridines ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informez-les sur les effets secondaires, l'importance de l'adhésion et les signes d'alerte."
}
},
{
"@type": "Question",
"name": "Comment les thiénopyridines agissent-elles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles inhibent l'agrégation plaquettaire, réduisant ainsi le risque de caillots."
}
},
{
"@type": "Question",
"name": "Quelles sont les principales thiénopyridines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principales sont le clopidogrel, le prasugrel et le ticagrelor."
}
},
{
"@type": "Question",
"name": "Quand prescrire des thiénopyridines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont prescrites après un infarctus, un AVC ou lors de procédures coronariennes."
}
},
{
"@type": "Question",
"name": "Comment surveiller le traitement par thiénopyridines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance inclut des tests de fonction plaquettaire et l'évaluation des saignements."
}
},
{
"@type": "Question",
"name": "Quels médicaments interagissent avec les thiénopyridines ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les AINS, les anticoagulants et certains antibiotiques peuvent interagir."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des thiénopyridines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des hémorragies graves, des réactions allergiques et des thrombocytopénies."
}
},
{
"@type": "Question",
"name": "Comment gérer une hémorragie due aux thiénopyridines ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Arrêtez le médicament, appliquez une pression sur la plaie et consultez un médecin immédiatement."
}
},
{
"@type": "Question",
"name": "Quels risques de thrombose sous thiénopyridines ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un risque de thrombose persiste si le traitement est interrompu ou mal suivi."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux thiénopyridines ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une surveillance régulière et une éducation des patients."
}
},
{
"@type": "Question",
"name": "Quels signes d'une réaction allergique grave ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des difficultés respiratoires, un gonflement du visage et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de thrombose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, le tabagisme, l'hypertension et le diabète."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque thrombotique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque thrombotique augmente avec l'âge en raison de la diminution de la circulation sanguine."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'hérédité dans la thrombose ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux de thrombose augmentent le risque de développer des troubles thromboemboliques."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie affecte-t-il le risque thrombotique ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une mauvaise alimentation augmentent le risque de thrombose."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque de saignement ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants, les AINS et certains antibiotiques peuvent augmenter le risque de saignement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 16/02/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Jiangsu Vcare PharmaTech Co., Ltd., 15 Wanshou Road, Nanjing 211800, China.
Publications dans "Thiénopyridines" :
3 publications dans cette catégorie
Affiliations :
Jiangsu Vcare PharmaTech Co., Ltd., 15 Wanshou Road, Nanjing 211800, China.
Publications dans "Thiénopyridines" :
3 publications dans cette catégorie
Affiliations :
Jiangsu Vcare PharmaTech Co., Ltd., 15 Wanshou Road, Nanjing 211800, China.
Publications dans "Thiénopyridines" :
3 publications dans cette catégorie
Affiliations :
Jiangsu Vcare PharmaTech Co., Ltd., 15 Wanshou Road, Nanjing 211800, China.
Publications dans "Thiénopyridines" :
3 publications dans cette catégorie
Affiliations :
Hua Medicine (Shanghai) Ltd., 275 Ai Di Sheng Road, Shanghai 201203, China.
Publications dans "Thiénopyridines" :
3 publications dans cette catégorie
Affiliations :
State Key Laboratory of Natural Medicines and Center of Drug Discovery, College of Pharmacy, China Pharmaceutical University, 24 Tongjia Xiang, Nanjing 210009, China. Electronic address: hongbinsun@cpu.edu.cn.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo 11754, Egypt. dr.emannossier@gmail.com.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
Cardiology Department - University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Italy.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
Department of Biomedical Science and Human Oncology, Dermatological Clinic, University of Bari, 70124 Bari, Italy.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Natural and Biomimetic Drugs, Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Natural and Biomimetic Drugs, School of pharmaceutical Sciences, Peking University, Beijing, 100191, China.
College of Pharmacy, Inner Mongolia Medical University, Hohhot, 010110, China.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Natural and Biomimetic Drugs, Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: li.xuening@zs-hospital.sh.cn.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
Center of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China. Electronic address: yjcpu@yahoo.com.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China. Electronic address: dfzhong@simm.ac.cn.
Publications dans "Thiénopyridines" :
2 publications dans cette catégorie
Affiliations :
Centre of Chemistry (CQUM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Publications dans "Thiénopyridines" :
The thienopyridine family includes ticlopidine, clopidogrel and prasugrel which are antiplatelet drugs largely used, mainly associated to aspirin, for treatment of acute coronary syndromes and after p...
The present study investigates the management of thienopyridines hypersensitivity on the basis of published case reports and studies, comparing the pro and contro of pharmacological treatments, differ...
All the data seem to suggest that only working together, a cardio-allergy team of specialists may evaluate and offer the best approach to clinical decision-making for the individual patient....
Cold snare polypectomy (CSP) is a safe and effective method for removing polyps ≤10 mm. The aim of this study was to compare the risk of clinically significant bleeding and thromboembolic events after...
The study was a single-center, noninferiority, and randomized controlled study involving patients who received colonoscopy from October 2015 to October 2016. Patients receiving DAPT with polyps ≤10 mm...
Forty-two patients with 104 eligible polyps were allocated to the DAPT group, and 45 patients with 101 eligible polyps were allocated to the aspirin group. Patient demographic characteristics includin...
Clinically significant bleeding rate after CSP for polyps ≤10 mm in patients continuing to take DAPT was 2.4%. Therefore, CSP is a safe method for removing small polyps even in patients taking DAPT (C...
Whether anticoagulation benefits patients with heart failure (HF) in sinus rhythm is uncertain. The COMMANDER HF randomized clinical trial evaluated the effects of adding low-dose rivaroxaban to antip...
To examine whether low-dose rivaroxaban was associated with reduced thromboembolic events in patients enrolled in the COMMANDER HF trial....
Post hoc analysis of the COMMANDER HF multicenter, randomized, double-blind, placebo-controlled trial in patients with CAD and worsening HF. The trial randomized 5022 patients postdischarge from a hos...
Patients were randomly assigned to receive 2.5 mg of rivaroxaban given orally twice daily or placebo in addition to their standard therapy....
For this post hoc analysis, a thromboembolic composite was defined as either (1) myocardial infarction, ischemic stroke, sudden/unwitnessed death, symptomatic pulmonary embolism, or symptomatic deep v...
Of 5022 patients, 3872 (77.1%) were men, and the overall mean (SD) age was 66.4 (10.2) years. Over a median (interquartile range) follow-up of 19.6 (11.7-30.8) months, fewer patients assigned to rivar...
In this study, thromboembolic events occurred frequently in patients with HF, CAD, and sinus rhythm. Rivaroxaban may reduce the risk of thromboembolic events in this population, but these events are n...
ClinicalTrials.gov identifier: NCT01877915....
A continuous flow photooxygenation of 7-aminothieno[3,2-c]pyridin-4(5H)-ones to produce 7-iminothieno[3,2-c]pyridine-4,6(5H,7H)-diones has been developed, utilizing ambient air as the sole reactant. N...
The anti-IgE Omalizumab may be helpful to treat clopidogrel hypersensitivity without stopping thienopyridine administration in patients requirining continuous antiplatellet therapy after coronary sten...
Vicagrel is a new antiplatelet pro-drug based on clopidogrel sulfur lactone metabolites. The purpose of the study was to evaluate the safety, tolerability, and pharmacodynamics (PD) of vicagrel in hea...
A series of novel thienopyridine derivatives were designed and synthesized as P2Y...
The aim of this study was to evaluate prospectively the clinical impact of routine transmission of CYP2C19 genotype in the management of acute ST-segment elevation myocardial infarction with primary p...
Response to clopidogrel differs widely among patients, notably because of CYP2C19 genetic polymorphisms....
CYP2C19 genotype (6 alleles) was determined centrally and communicated within 4.1 ± 1.9 days of primary percutaneous coronary intervention in 1,445 patients with ST-segment elevation myocardial infarc...
Detection of LOF alleles resulted in adjustment of P2Y...
In a real-world setting, a complete CYPC2C19 genotype can be mostly determined in <7 days using analysis of saliva deoxyribonucleic acid collected during the in-hospital phase among patients with ST-s...
Unfortunately, the article's Supplementary File Link is not working and the ESM material....
To develop of an effective synthetic methodology for biologically relevant thienopyridines, a concise and efficient protocol is described for the synthesis of a series of substituted thienopyridine an...